Leaflet OPTIRAY 350 741mg / ml solution for injection / infusion


Indicated for: diagnostic imaging contrast enhancement

Route of administration: injectable / infusion

Substance: ioversol (contrast agent)

ATC: V08AB07 (Various | X-ray contrast media, iodinated | Watersoluble, nephrotropic, low osmolar x-ray contrast media)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Ioversol is an iodinated contrast agent used in medical imaging, including computed tomography (CT) and angiography. It enhances the visualization of internal body structures by increasing the contrast between tissues.

The medication is administered intravenously or intra-arterially under the supervision of a specialist.

Side effects may include nausea, vomiting, a warm sensation, or allergic reactions. In rare cases, kidney dysfunction or anaphylactic reactions may occur.

Patients should inform their doctor about any allergies or kidney conditions before administration. Pregnant or breastfeeding women should consult a specialist before use.

General data about OPTIRAY 350 741mg / ml

  • Substance: ioversol
  • Date of last drug list: 01-06-2026
  • Commercial code: W63701025
  • Concentration: 741mg / ml
  • Pharmaceutical form: solution for injection / infusion
  • Packing volume: 50ml
  • Product type: original
  • Price: 2151.89 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: GUERBET IRELAND UNLIMITED COMPANY - IRLANDA
  • Holder: GUERBET - FRANTA
  • Number: 8366/2015/25
  • Shelf life: 3 years

Concentrations available for ioversol

  • 339mg/ml
  • 509mg/ml
  • 636mg/ml
  • 678mg/ml
  • 741mg/ml